Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Direxion Daily S&P 500 Bear 3X Shares ETF
SPXS
5
ProShares UltraPro Short S&P500 ETF
SPXU
US Stock MarketDetailed Quotes
TOVX Theriva Biologics
- 1.386
- -0.014-1.01%
Trading May 2 13:59 ET
3.86MMarket Cap-0.07P/E (TTM)
1.416High1.350Low10.28KVolume1.405Open1.400Pre Close14.25KTurnover0.43%Turnover RatioLossP/E (Static)2.78MShares12.27852wk High0.20P/B3.32MFloat Cap0.95652wk Low--Dividend TTM2.40MShs Float52089843.750Historical High--Div YieldTTM4.72%Amplitude0.956Historical Low1.387Avg Price1Lot Size
Theriva Biologics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -49.91%11.61M | -49.91%11.61M | -47.34%16.41M | -51.55%16.59M | -49.38%18.26M | -44.53%23.18M | -44.53%23.18M | -38.28%31.16M | -34.47%34.25M | -36.36%36.08M |
| -Cash and cash equivalents | -49.91%11.61M | -49.91%11.61M | -47.34%16.41M | -51.55%16.59M | -49.38%18.26M | -44.53%23.18M | -44.53%23.18M | -38.28%31.16M | -34.47%34.25M | -36.36%36.08M |
| Receivables | 71.29%3.32M | 71.29%3.32M | 27.11%2M | 565.52%1.93M | 718.88%1.91M | 739.83%1.94M | 739.83%1.94M | 635.98%1.58M | 4.32%290K | -86.46%233K |
| -Taxes receivable | 71.29%3.32M | 71.29%3.32M | 27.11%2M | 1,240.28%1.93M | 47,600.00%1.91M | 2,129.89%1.94M | 2,129.89%1.94M | 635.98%1.58M | -48.20%144K | -96.85%4K |
| -Other receivables | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --146K | -85.63%229K |
| Prepaid assets | -40.99%1.35M | -40.99%1.35M | -44.78%1.12M | -65.22%1.19M | -62.73%1.49M | -34.74%2.29M | -34.74%2.29M | 0.25%2.03M | 46.20%3.43M | 249.39%3.99M |
| Total current assets | -40.59%16.28M | -40.59%16.28M | -43.82%19.53M | -48.07%19.72M | -46.26%21.66M | -39.80%27.4M | -39.80%27.4M | -34.07%34.77M | -30.83%37.97M | -32.33%40.3M |
| Non current assets | ||||||||||
| Net PPE | -29.30%1.54M | -29.30%1.54M | -21.53%1.74M | -17.81%1.86M | -15.52%2.01M | 41.26%2.18M | 41.26%2.18M | 47.21%2.22M | 43.12%2.26M | 44.91%2.38M |
| -Gross PPE | -22.18%2.48M | -22.18%2.48M | -16.04%2.67M | -14.06%2.74M | -6.99%3.05M | 32.13%3.18M | 32.13%3.18M | 35.68%3.18M | 33.35%3.19M | 17.17%3.28M |
| -Accumulated depreciation | 6.69%-935K | 6.69%-935K | 3.34%-927K | 4.95%-884K | -15.61%-1.04M | -15.84%-1M | -15.84%-1M | -14.85%-959K | -14.39%-930K | 22.27%-897K |
| Goodwill and other intangible assets | -31.81%17.36M | -31.81%17.36M | -23.51%18.65M | -17.77%20.64M | -0.79%24.89M | 3.16%25.46M | 3.16%25.46M | 0.17%24.39M | -2.50%25.1M | -9.36%25.09M |
| -Goodwill | --0 | --0 | --0 | -73.94%1.47M | -0.78%5.57M | 3.17%5.7M | 3.17%5.7M | 28.35%5.46M | 8.41%5.62M | -3.31%5.62M |
| -Other intangible assets | -12.13%17.36M | -12.13%17.36M | -1.45%18.65M | -1.56%19.18M | -0.79%19.32M | 3.16%19.76M | 3.16%19.76M | -5.79%18.93M | -5.25%19.48M | -10.97%19.47M |
| Other non current assets | -5.00%171K | -5.00%171K | 5.20%182K | 43.09%176K | 43.09%176K | 47.54%180K | 47.54%180K | 53.10%173K | 3.36%123K | -2.38%123K |
| Total non current assets | -31.44%19.07M | -31.44%19.07M | -23.16%20.58M | -17.50%22.68M | -1.86%27.07M | 5.60%27.82M | 5.60%27.82M | 3.14%26.78M | 0.15%27.48M | -6.31%27.59M |
| Total assets | -35.98%35.35M | -35.98%35.35M | -34.83%40.11M | -35.23%42.39M | -28.22%48.73M | -23.16%55.22M | -23.16%55.22M | -21.79%61.55M | -20.51%65.45M | -23.72%67.89M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 11.56%859K | 11.56%859K | -9.24%756K | 26.18%935K | 18.96%571K | -15.85%770K | -15.85%770K | -4.14%833K | -34.19%741K | -66.78%480K |
| -accounts payable | 11.56%859K | 11.56%859K | -9.24%756K | 26.18%935K | 18.96%571K | -15.85%770K | -15.85%770K | 8.18%833K | -26.12%741K | -64.55%480K |
| Current accrued expenses | -1.37%4.33M | -1.37%4.33M | -43.57%3.75M | 37.04%3.49M | 30.83%3.33M | 55.94%4.39M | 55.94%4.39M | 163.49%6.65M | 0.47%2.55M | 42.54%2.54M |
| Current debt and capital lease obligation | 9.09%600K | 9.09%600K | 15.21%606K | 10.79%575K | 11.33%560K | 101.47%550K | 101.47%550K | 151.67%526K | 182.07%519K | 159.28%503K |
| -Current debt | -3.17%61K | -3.17%61K | 0.00%65K | -7.46%62K | -6.06%62K | 10.53%63K | 10.53%63K | 25.00%65K | 19.64%67K | -2.94%66K |
| -Current capital lease obligation | 10.68%539K | 10.68%539K | 17.35%541K | 13.50%513K | 13.96%498K | 125.46%487K | 125.46%487K | 193.63%461K | 253.13%452K | 246.83%437K |
| Current deferred liabilities | 78.15%1.61M | 78.15%1.61M | 74.48%916K | --880K | --886K | --906K | --906K | --525K | ---- | ---- |
| Other current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -46.48%4.98M | -34.26%4.91M |
| Current liabilities | 12.57%7.59M | 12.57%7.59M | -16.24%7.32M | -25.03%6.85M | -30.28%6.01M | -4.56%6.74M | -4.56%6.74M | -33.72%8.74M | -31.14%9.13M | -21.47%8.62M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -39.84%965K | -39.84%965K | -33.20%1.13M | -31.68%1.26M | -25.69%1.46M | 13.92%1.6M | 13.92%1.6M | 17.29%1.7M | 21.33%1.84M | 24.18%1.96M |
| -Long term debt | -43.21%92K | -43.21%92K | -34.67%98K | -39.22%93K | -0.63%159K | -26.70%162K | -26.70%162K | -25.74%150K | -29.17%153K | -30.13%160K |
| -Long term capital lease obligation | -39.46%873K | -39.46%873K | -33.05%1.04M | -31.00%1.16M | -27.91%1.3M | 21.48%1.44M | 21.48%1.44M | 24.28%1.55M | 29.74%1.68M | 33.38%1.8M |
| Non current deferred liabilities | -15.89%762K | -15.89%762K | -82.21%229K | -53.78%440K | -49.35%664K | -44.00%906K | -44.00%906K | -63.11%1.29M | -72.84%952K | -64.83%1.31M |
| Other non current liabilities | 11.14%6.97M | 11.14%6.97M | 14.37%6.79M | 7.41%6.2M | 19.75%6.48M | -12.99%6.27M | -12.99%6.27M | 145.35%5.94M | 143.18%5.77M | 15.36%5.41M |
| Total non current liabilities | -0.96%8.7M | -0.96%8.7M | -8.61%8.15M | -7.78%7.9M | -0.96%8.6M | -14.19%8.78M | -14.19%8.78M | 21.27%8.92M | 15.81%8.56M | -13.16%8.68M |
| Total liabilities | 4.92%16.29M | 4.92%16.29M | -12.39%15.47M | -16.68%14.74M | -15.57%14.61M | -10.26%15.52M | -10.26%15.52M | -14.04%17.66M | -14.33%17.7M | -17.51%17.3M |
| Shareholders'equity | ||||||||||
| Share capital | -99.89%3K | -99.89%3K | -99.89%3K | -35.72%1.77M | 0.07%2.75M | -0.55%2.74M | -0.55%2.74M | 0.07%2.75M | 17,100.00%2.75M | 1,640.51%2.75M |
| -common stock | 200.00%3K | 200.00%3K | -83.33%3K | 27.78%23K | 12.50%18K | -93.75%1K | -93.75%1K | 12.50%18K | 12.50%18K | -89.87%16K |
| -Preferred stock | --0 | --0 | --0 | -36.14%1.75M | 0.00%2.73M | 0.00%2.73M | 0.00%2.73M | 0.00%2.73M | --2.73M | --2.73M |
| Retained earnings | -8.29%-334.97M | -8.29%-334.97M | -8.78%-330.53M | -7.41%-322.8M | -6.44%-314.48M | -6.31%-309.32M | -6.31%-309.32M | -6.47%-303.83M | -7.13%-300.53M | -7.22%-295.45M |
| Paid-in capital | 2.59%355.5M | 2.59%355.5M | 2.60%355.33M | 1.01%349.67M | 0.82%346.68M | 0.81%346.54M | 0.81%346.54M | 0.78%346.31M | 0.78%346.18M | 0.18%343.88M |
| Less: Treasury stock | 0.00%288K | 0.00%288K | 0.00%288K | 0.00%288K | 0.00%288K | 0.00%288K | 0.00%288K | --288K | --288K | --288K |
| Gains losses not affecting retained earnings | -3,781.25%-1.18M | -3,781.25%-1.18M | 110.59%112K | -99.16%-709K | -76.07%-537K | 104.71%32K | 104.71%32K | 62.80%-1.06M | 72.97%-356K | -268.51%-305K |
| Total stockholders'equity | -51.97%19.07M | -51.97%19.07M | -43.86%24.64M | -42.11%27.65M | -32.54%34.12M | -27.25%39.7M | -27.25%39.7M | -24.53%43.88M | -22.57%47.75M | -25.64%50.59M |
| Total equity | -51.97%19.07M | -51.97%19.07M | -43.86%24.64M | -42.11%27.65M | -32.54%34.12M | -27.25%39.7M | -27.25%39.7M | -24.53%43.88M | -22.57%47.75M | -25.64%50.59M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. Do you think Buffett was scooping up stocks during the recent dip? 2. In the face of market changes, do you prefer to stick
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now